Seeking Alpha

Dipexium files for $35M IPO

  • Dipexium Pharma has filed to raise up to $35M in an IPO on Nasdaq and intends to trade under the ticker symbol DPRX.
  • Dipexium is a late-stage pharmaceutical company focused on the development an antibiotic cream call Locilex, which is based on an extract from the skin of the African Clawed Frog.
  • Dipexium is initially targeting Locilex for the treatment of mild infections of diabetic foot ulcers. The company plans to start Phase III trials of Locilex in Q2. (S-1)
Comments (1)
  • aftab1234
    , contributor
    Comment (1) | Send Message
    do not invest in this company. The product was purchased from another company that went bankrupt (or something similar) after FDA did not approve Locilex. Do a google search on Locilex. Be very aware and stay away from this company; much better value out there
    23 Mar, 10:38 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: